Results for tag: "Thiotepa"

Thiotepa is an alkylating agent used in the treatment of various types of cancer, including breast, ovarian, and bladder cancer. It is also used to treat lymphomas, leukemias, and other malignancies. Thiotepa is administered intravenously or intraperitoneally, and is often used in combination with other chemotherapy drugs. It works by damaging the DNA of cancer cells, preventing them from growing and dividing. Thiotepa is a generic drug, and is available in both brand-name and generic formulations. It is widely used in oncology, and is often prescribed in combination with other chemotherapy drugs. The drug is available in both oral and injectable forms, and is typically administered in a hospital setting. The Thiotepa market is highly competitive, with several major pharmaceutical companies competing for market share. Companies such as Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca are all major players in the market. Other companies such as Teva Pharmaceuticals, Novartis, and Sanofi also have a presence in the market. Show Less Read more